Plato Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
4,113
-546
| -12% | -$177K | 0.1% | 211 |
|
|
2025
Q1 | $1.27M | Sell |
4,659
-888
| -16% | -$242K | 0.11% | 212 |
|
|
2024
Q4 | $1.31M | Buy |
5,547
+845
| +18% | +$200K | 0.1% | 225 |
|
|
2024
Q3 | $1.29M | Buy |
4,702
+1,173
| +33% | +$322K | 0.1% | 204 |
|
|
2024
Q2 | $858K | Sell |
3,529
-980
| -22% | -$238K | 0.08% | 225 |
|
|
2024
Q1 | $674K | Buy |
4,509
+4,346
| +2,666% | +$650K | 0.07% | 240 |
|
|
2023
Q4 | $31.2K | Buy |
+163
| New | +$31.2K | 0.04% | 277 |
|